Galmed Pharmaceuticals Ltd. (GLMD)
NASDAQ: GLMD · Real-Time Price · USD
3.050
-0.070 (-2.24%)
Dec 20, 2024, 4:00 PM EST - Market closed
Galmed Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 9.72 | 2.86 | 2.02 | 2.88 | 6.95 | 15.93 | Upgrade
|
| Short-Term Investments | 7.42 | 9.78 | 11.77 | 31.93 | 43.94 | 59.56 | Upgrade
|
| Cash & Short-Term Investments | 17.14 | 12.64 | 13.79 | 34.82 | 50.89 | 75.49 | Upgrade
|
| Cash Growth | 28.75% | -8.29% | -60.40% | -31.58% | -32.59% | -16.30% | Upgrade
|
| Other Receivables | 0.43 | 0.17 | 0.16 | 0.08 | 0.07 | 0.23 | Upgrade
|
| Receivables | 0.43 | 0.17 | 0.16 | 0.08 | 0.07 | 0.23 | Upgrade
|
| Prepaid Expenses | - | 0.32 | 0.67 | 1.05 | 0.75 | 0.6 | Upgrade
|
| Restricted Cash | 0.12 | 0.12 | 0.11 | 0.11 | 0.11 | 0.11 | Upgrade
|
| Total Current Assets | 17.69 | 13.24 | 14.72 | 36.05 | 51.81 | 76.43 | Upgrade
|
| Property, Plant & Equipment | - | 0.13 | 0.34 | 0.55 | 0.57 | 0.71 | Upgrade
|
| Long-Term Investments | 3.27 | 3.27 | 1.5 | - | - | - | Upgrade
|
| Total Assets | 20.95 | 16.63 | 16.56 | 36.61 | 52.38 | 77.14 | Upgrade
|
| Accounts Payable | 1.34 | 1.88 | 2.56 | 4.87 | 7.05 | 6 | Upgrade
|
| Current Portion of Leases | - | 0.04 | 0.17 | 0.21 | 0.2 | - | Upgrade
|
| Other Current Liabilities | 1.17 | 0.83 | 0.36 | 0.8 | 0.76 | 0.94 | Upgrade
|
| Total Current Liabilities | 2.51 | 2.75 | 3.09 | 5.88 | 8.01 | 6.93 | Upgrade
|
| Long-Term Leases | - | - | 0.04 | 0.23 | 0.22 | 0.35 | Upgrade
|
| Total Liabilities | 2.51 | 2.75 | 3.14 | 6.11 | 8.23 | 7.29 | Upgrade
|
| Common Stock | 0.67 | 0.21 | 0.07 | 0.07 | 0.06 | 0.06 | Upgrade
|
| Additional Paid-In Capital | 215.37 | 207.08 | 200.14 | 198.77 | 179.53 | 176.7 | Upgrade
|
| Retained Earnings | -197.26 | -192.95 | -186.04 | -168.17 | -135.71 | -106.94 | Upgrade
|
| Comprehensive Income & Other | -0.34 | -0.45 | -0.75 | -0.17 | 0.27 | 0.04 | Upgrade
|
| Shareholders' Equity | 18.44 | 13.88 | 13.42 | 30.5 | 44.15 | 69.85 | Upgrade
|
| Total Liabilities & Equity | 20.95 | 16.63 | 16.56 | 36.61 | 52.38 | 77.14 | Upgrade
|
| Total Debt | - | 0.04 | 0.22 | 0.44 | 0.42 | 0.35 | Upgrade
|
| Net Cash (Debt) | 17.14 | 12.6 | 13.57 | 34.38 | 50.47 | 75.14 | Upgrade
|
| Net Cash Growth | 28.75% | -7.13% | -60.53% | -31.88% | -32.84% | -16.69% | Upgrade
|
| Net Cash Per Share | 30.67 | 54.60 | 97.14 | 251.58 | 426.87 | 640.56 | Upgrade
|
| Filing Date Shares Outstanding | 1.51 | 0.5 | 0.14 | 0.14 | 0.14 | 0.12 | Upgrade
|
| Total Common Shares Outstanding | 1.51 | 0.42 | 0.14 | 0.14 | 0.12 | 0.12 | Upgrade
|
| Working Capital | 15.17 | 10.49 | 11.63 | 30.18 | 43.8 | 69.5 | Upgrade
|
| Book Value Per Share | 12.23 | 33.01 | 95.87 | 218.80 | 372.67 | 594.79 | Upgrade
|
| Tangible Book Value | 18.44 | 13.88 | 13.42 | 30.5 | 44.15 | 69.85 | Upgrade
|
| Tangible Book Value Per Share | 12.23 | 33.01 | 95.87 | 218.80 | 372.67 | 594.79 | Upgrade
|
| Machinery | - | 0.79 | 0.79 | 0.79 | 0.79 | 0.79 | Upgrade
|
| Leasehold Improvements | - | 0.24 | 0.24 | 0.23 | 0.22 | 0.2 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.